Western Blotting (WB), Immunohistochemistry (Paraffin-embedded Sections) (IHC (p))
Purification
This antibody is purified through a protein A column, followed by peptide affinity purification.
Immunogène
This PHLDA2 antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 90-119 amino acids from the C-terminal region of human PHLDA2.
PHLDA2
Reactivité: Humain, Rat
WB, IF (cc), IF (p)
Hôte: Lapin
Polyclonal
AbBy Fluor® 350
Indications d'application
For WB starting dilution is: 1:1000
For IHC-P starting dilution is: 1:10~50
Restrictions
For Research Use only
Format
Liquid
Concentration
0.5 mg/mL
Buffer
Supplied in PBS with 0.09 % (W/V) sodium azide.
Agent conservateur
Sodium azide
Précaution d'utilisation
This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
Stock
4 °C,-20 °C
Stockage commentaire
Store at 4°C for three months and -20°C, stable for up to one year. As with all antibodies care should be taken to avoid repeated freeze thaw cycles. Antibodies should not be exposed to prolonged high temperatures.
Antigène
PHLDA2
(Pleckstrin Homology-Like Domain, Family A, Member 2 (PHLDA2))
anticorps PHLDA2, anticorps ipl, anticorps phlda2, anticorps BRW1C, anticorps BWR1C, anticorps HLDA2, anticorps IPL, anticorps TSSC3, anticorps Ipl, anticorps Tssc3, anticorps zgc:110459, anticorps pleckstrin homology like domain family A member 2, anticorps Pleckstrin homology-like domain family A member 2, anticorps pleckstrin homology like domain, family A, member 2, anticorps pleckstrin homology-like domain, family A, member 2, anticorps pleckstrin homology-like domain, family A, member 2 L homeolog, anticorps PHLDA2, anticorps phla2, anticorps Phlda2, anticorps phlda2.L, anticorps phlda2
Sujet
This gene is located in a cluster of imprinted genes on chromosome 11p15.5, which is considered to be an important tumor suppressor gene region. Alterations in this region may be associated with the Beckwith-Wiedemann syndrome, Wilms tumor, rhabdomyosarcoma, adrenocortical carcinoma, and lung, ovarian, and breast cancer. This gene has been shown to be imprinted, with preferential expression from the maternal allele in placenta and liver.